Retatrutide is a novel molecule showing remarkable potential in weight management . This drug acts as a dual activator for both GLP-1 and GIP pathways , contributing to better glycemic control and reduced abdominal adipose tissue . Preliminary trial results suggest impressive body reduction and favorable physiological effects in patients with being